No Data
Amneal Pharmaceuticals Begins Supplying Generic Version of Narcan
By Ben Glickman Amneal Pharmaceuticals said it had begun distributing the generic version of its over-the-counter overdose treatment to retail pharmacies. The drugmaker said Wednesday that it was su
Express News | Amneal Pharmaceuticals: Expects to Have Capacity to Produce About 10 Mln Two-Packs Annually at Its New Jersey Manufacturing Facility, Starting 2025
Amneal: Entered Distribution Agreement With California, Actively Engaging Other States and Municipalities to Expand Access >AMRX
Amneal: Entered Distribution Agreement With California, Actively Engaging Other States and Municipalities to Expand Access >AMRX
Amneal: Begins Supplying Over-the-Counter Naloxone Hydrochloride Nasal Spray to U.S. Retail Pharmacies and California
Amneal: Begins Supplying Over-the-Counter Naloxone Hydrochloride Nasal Spray to U.S. Retail Pharmacies and California
Amneal to Participate at Upcoming Investor Conference
Amneal Pharmaceuticals, Inc. (NASDAQ:AMRX) announced today that Chirag Patel, Co-Chief Executive Officer and President, and Tasos Konidaris, Chief Financial Officer, will participate in the 2024 Jefferies Healthcare
Independent Director Deborah Autor Sold A Bunch Of Shares In Amneal Pharmaceuticals
We'd be surprised if Amneal Pharmaceuticals, Inc. (NASDAQ:AMRX) shareholders haven't noticed that the Independent Director, Deborah Autor, recently sold US$256k worth of stock at US$6.74 per share.